We collaborate with consultants and leading experts with recognized expertise
in widely varying fields.
| Amy F. Boggs, Ph.D. |
Amy Boggs has ten years experience assisting biotech
start-up companies to establish research portfolios through internal
drug discovery research and in-licensing. A dedicated science-business
liaison, Dr. Boggs offers strategic research planning, writing, and
technology assessment skills to support your business objectives.
|
| Audrey Erbes, Ph.D. |
Audrey Erbes is a life-science business development and marketing
consultant who provides clients with a global perspective to her assignments.
She has 30 years of business development and marketing experience
and held management positions in marketing and business development
functions in the US and abroad. Her international experience includes
Europe, Asia/Pacific/Canada.
|
| Shauna Farr-Jones, Ph.D. |
Shauna Farr-Jones is a biochemist with experience in academic research,
business development, and medical writing. Dr. Farr-Jones received
a B.Sc. in Chemistry from Southampton University, UK, and her Ph.D.
in Biochemistry from Tufts University in Boston. She has certificates
in Marketing and Finance from the University of California Berkeley
Extension.
|
| Juan N Walterspiel, MD |
Juan N Walterspiel served as International Clinical Leader at Hoffmann-La
Roche, Medical Director at Pfizer and VP for clinical Research &
Development at two start-up companies. He is board certified in Pediatrics
and Infectious Diseases with licenses for the European Union and the
states of CT, GA, TX and CA. Dr. Walterspiel’s academic career
encompassed professorships at UT, Emory and Yale. He maintains his
commitment to the health sciences and medical care at Stanford University
and is currently working as an independent consultant to the Pharmaceutical
and Biotechnology industry.
|
David T. Davies,
Ph.D. |
David T. Davies has 25 years experience in medicinal chemistry at
a major pharmaceutical company (GSK) most of which was spent in the
antibacterial area. He has been at the forefront of two separate areas
that have progressed from hit to Phase I and is an inventor on about
25 patents in these areas. He has recently embarked on a new career,
working with biotechnology companies supporting strategy, targets
and synthetic routes in support of their medicinal chemistry efforts
and also has an academic position at University College London (UCL)
as a Research Fellow in antibacterial medicinal chemistry..
|
| Inge C Gyssens, MD Ph.D. |
Inge. C Gyssens is an internist and subspecialist in Infectious
Diseases. Until recently she was appointed at the
department of Medical Microbiology and Infectious Diseases at Erasmus
University Medical Center in Rotterdam.
Dr. Gyssens’ research group has been involved in animal model
pharmacokinetics/dynamics and clinical trials. She has conducted audits
and intervention studies to improve the quality of prophylaxis and
therapy of infectious diseases.
Currently, Dr Gyssens has published and lectured extensively on the
topics of abscess research and antibiotic policies.
|
| Johanna K Lang, Ph.D. |
Johann Lang has 15+ years experience in pharmaceutical/biotech
product development. She works with clients to develop and implement
strategies for product manufacturing and testing in compliance with
FDA regulations. Johanna Lang focuses on services related to
good manufacturing practices (GMP), US FDA submissions, validation,
standard operating procedures (SOP), and
contract manufacturer/laboratory management.
|
| Kent Iverson |
Kent Iverson is an independent biopharmaceutical manufacturing and
development consultant serving clients based in North America, the
Asia/Pacific region and Europe. His experience includes Chemistry,
Manufacturing and Controls Submission Planning and Development, Supply
Chain Strategy and Evaluation, Biopharmaceutical Manufacturing Facility
Design, Contract Manufacturing Planning and Execution, Bioprocess
Design, Optimization and Troubleshooting, and CMC Evaluation Supporting
Merger/Acquisition Transactions.
|
